Oramed Pharmaceuticals
ORMP
ORMP
56 hedge funds and large institutions have $12.1M invested in Oramed Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 56 → 56 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Holders
56
Holding in Top 10
–
Calls
$136K
Puts
$52K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.21M | |
| 3 | +$1.11M | |
| 4 |
Renaissance Technologies
New York
|
+$686K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$580K |
Top Sellers
| 1 | -$401K | |
| 2 | -$232K | |
| 3 | -$108K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$71.2K |
| 5 |
VF
Virtu Financial
New York
|
-$45K |